Carl Zingmark
Umea, AC, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Parvimonas micra forms a distinct bacterial network with oral pathobionts in colorectal cancer patients.
Journal: Journal of translational medicine
Published: July 02, 2024
Opposing roles by KRAS and BRAF mutation on immune cell infiltration in colorectal cancer - possible implications for immunotherapy.
Journal: British journal of cancer
Published: May 24, 2023
Prognostic genome and transcriptome signatures in colorectal cancers.
Journal: Nature
Published: April 24, 2023
Porphyromonas gingivalis in Colorectal Cancer and its Association to Patient Prognosis.
Journal: Journal of Cancer
Published: February 09, 2023
Plasma Concentrations of Gut Hormones Acyl Ghrelin and Peptide YY and Subsequent Risk of Colorectal Cancer and Molecular Tumor Subtypes.
Journal: Cancer prevention research (Philadelphia, Pa.)
Published: July 07, 2022
Parvimonas micra is associated with tumour immune profiles in molecular subtypes of colorectal cancer.
Journal: Cancer immunology, immunotherapy : CII
Published: May 28, 2021
A modified protein marker panel to identify four consensus molecular subtypes in colorectal cancer using immunohistochemistry.
Journal: Pathology, research and practice
Published: October 06, 2020
Parvimonas micra as a putative non-invasive faecal biomarker for colorectal cancer.
Journal: Scientific reports
Published: March 23, 2020
C-reactive Protein and Future Risk of Clinical and Molecular Subtypes of Colorectal Cancer.
Journal: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
Published: October 30, 2019
Last Updated: 09/26/2026